VKML Viking Minerals, Inc. & CIGX Star Scientific, Inc. for 09/15

Viking Minerals, Inc. VKML

VKML is a gold play that we mentioned earlier in the Summer, which subsequently made for itself a bottom, moving from .02 to .10, and settling back to its level of .085. We believe that VKML could very well see another 40-50% in gains once the current resistance level of .10 is breached, and the chart certainly looks primed for another surge.

The company recently released positive assay results from its main claim, known as the Dolly Varden property, and at this time we are awaiting further information.

Copper prices are at an all-time high with an overseas demand from Asia which looks to keep prices at these advanced levels or even greater. Copper is one of the most profitable minerals to mine, with the overall profit being around 65%, a margin which is even better than the associated cost of mining gold.

VKML figures to make big strides in the future with expected Copper production reaching more than 10X the average for mines in the area.

PR regarding the assay claim:

PHOENIX, ARIZONA, Sep 06, 2011 (MARKETWIRE via COMTEX) — VIKING MINERALS INC (OTCBB: VKML) ( www.vikingmineralsinc.com) reports up to 5.23% copper from its first five assay results at the Dolly Varden Claims, in Elko County, Nevada.

The five samples were shipped to the ALS Chemex lab in North Vancouver, Canada.

Company President Charles Irizarry stated “The Dolly Varden Property continues to prove it’s self as being highly mineralised with the potential for bulk tonnage copper, gold and silver recovery. The results of up to 5.23% Copper from our first hole have exceeded our expectations. Especially when considering the neighbouring Robinson Mine averages 0.5% Copper. There is growing anticipation on what our next set of results will bring.”

http://www.vikingmineralsinc.com/

Star Scientific, Inc. CIGX

Our original call of CIGX came over a year ago, at which time the stock was trading at 1.55. In the months that followed it had hit a high of 5.35 (On May 31st) marking an enormous gain of 235%

We mentioned CIGX again back on August 31st, when the stock was trading as low as 2.23. Yesterday, the stock hit 3.10, for a gain of 39% and marking the third day in a row of gains.

We had originally called the play as having high rebound potential, and it turns out we were correct. CIGX appeared on the NASDAQ top gainers list this week.

ELAY eLayaway, Inc. – Inside Today’s Penny Stock Newsletter


eLayaway, Inc. ELAY

We like ELAY not only for its sharp performance on the stock end of things, but also for the excellent business model they possess in a somewhat forgotten industry. Layaway fell somewhat out of popularity during the 90’s as the American economy enjoyed its last real boom. Now, in the heart of a recession, the option to pay for retail items over time begins to gain ground on traditional methods of payment.
ELAY’s business is geared perfectly toward a recession economy. People still want high value items, yet may not be able to afford the full price all at once.Just take a look at this article on debtfreeadventure.com to see how some people are viewing this old method of payment in a whole new light: Layaway is Back
Whether it be shopping, travel, healthcare needs, or checking out your favorite sporting events, ELAY has it covered through their different divisions, which handle these different types of purchases.

Over the next few years, we can see this business growing exponentially, especially in the event that America’s economic slump continues.

RECENT ELAY PRs:

Layaway Credited With Helping Retail Giant – Aug. 23rd

Merry Christmas in August, From eLayaway – Aug 17th

CHART:

Over the past 6 months, ELAY has made many bounces from the .10-.15 range, to the .20-.24 range, for gains from anywhere between 50-100%  Looking at the chart, the stock just bounced off a bottom at .11, just as the RSI was coming off of being oversold, as well as a cross of the MACD indicator. These are all indicators that clearly allude to another run in the making.
—
For more info visit: http://elayaway.com

DGHG – Diversified Global Holdings Group, Inc. Inside Today’s Penny Stock Report

Diversified Global Holdings Group, Inc. DGHG

DGHG is a new pick for us this morning; we are excited about the opportunity to mention such an intrinsically undervalued stock. There are several indications that this stock’s actual value is significantly higher than the current PPS of 1.16.

Value Could Approach $2.00+ per Share based on these facts and figures: 

  • Diversified Global recently reported $203M, an equivalent of $2.33 per share, in shareholders’ equity, which means that the current stock price is trading roughly 100% lower than actual valuation.
  • Excluding land, equipment and the like, DGHG’s total assets are around $0.38 per share, which represents a fairly significant percentage of the share price.
  • Diversified Global recently reported bottom-line growth rates of 256%, according to the latest 10-Q.
  • The company reduced its share count last quarter by 6.7%.

These are just a few of the points that lead us to the conclusion that Diversified Global Holdings Inc. (OTCQB: DGHG) may be an emerging stock with high growth potential. Between the company’s strong growth and profitability, not to mention its apparent gross undervaluation on today’s market, we are led to the assumption that at current levels in the 1.10’s, DGHG is an absolute steal of a buy. We will certainly be moving to acquire some of these highly discounted shares.

 SEC Filings

http://www.diversifiedglobalholdings.com/

EMXC eMax Holdings Corp. & BOCX Biocurex, Inc – Today’s Report

BioCurex, Inc BOCX

 On Friday, BOCX dipped to .0357 within the first 15 minutes of trading, and subsequently found a high of .047 before backtracking to .04. That means a vigilant trader could have made a 32% gain on the stock during Friday’s session.

It seems as if BOCX is trying to feel out a solid bottom after some really great news was released on Thursday, outlining the company’s new blood test that can supposedly detect prostate cancer, thereby rendering two-thirds of all biopsies unnecessary.

Often after a huge PR, it can take a few trading days for a stock to find its footing, but based on the extremely relevant nature of the PR itself, BOCX should come out of it just fine.

eMax Holdings Corp. EMXC

EMXC had a selloff early last week to .0007, only to bounce back to .0015 by Friday’s close. A lot has been happening with the company as illustrated from the list below outlining EMXC‘s recent progress and achievements.

1. eMax Worldwide is currently working towards changing transfer agents. 

 2. The company has retained new securities counsel of Martin & Pritchett, P.A.. with offices in Charlotte, NC, and Salt Lake City, UT

 3. eMax has opened new offices at Orlando’s Universal Studios Florida Production Group Complex.

 4. eMax Worldwide has added Armando Amiralli to their Board of Directors and as VP of Financial Investments

 5.  eMax Worldwide and eMax Media’s SEC attorneys are currently preparing the required filings and necessary registration statements to be filed regarding current dividend distributions.

 6. eMax Worldwide has renewed its subscription for its annual full disclosure service with otcmarkets.com (formerly pinksheets.com)

 7. The company completed filing articles of amendment to decrease their authorized common stock from 3,500,000,000 to 2,000,000,000 shares. 

We have been on EMXC for quite awhile, and the stock certainly has been good to us, however it is just now beginning to look like the company is really striving toward adding shareholder value in a decisive yet responsible manner, which only excites us further moving forward.

BOCX, CIGX & PASO Inside Today’s Penny Stock Newsletter

Patient Access Solutions, Inc. PASO

Two weeks back, we reported that PASO was trading at its 52-week low, and we felt that the bottom was being solidified in place. Trading on Thursday pushed the price of PASO stock to .0009, which incidentally, could have made savvy traders 50-80% in gains.

As if the increased activity wasn’t enough to be satisfied, the company came with some post-market blockbuster news that could help fuel the continuation of momentum to close out the week strong.

PASO is a perfect example of why patience is key, even with some of our shorter-term plays, just a few weeks time can make a big difference.

HAUPPAUGE, N.Y., Sep 08, 2011 (BUSINESS WIRE) — Patient Access Solutions, Inc. (Pink Sheets: PASO), a leading provider of information technology solutions for the healthcare industry is pleased to announce its EMR management & support solution has been engaged and is being deployed with a Florida based hospital group.

The client is the largest faith based, non profit health care organization in Florida to participate in the EHR (Electronic Health Record) program and has a long standing pedigree as a national leader in the adoption of healthcare IT across its network of 6 hospitals comprising of more than 1,500 beds. This engagement serves as part of its continuing commitment to enable excellent quality care and services, will assist its more than 2,000 physicians in the adoption of Electronic Health Records in their private practices through an EHR Donation Program. The initial implementation expects to generate approximately $3 million in gross revenue over the next year for Patient Access Solutions.

Star Scientific, Inc. CIGX

We were discussing CIGX last Wednesday, at which time the PPS was sitting at 2.33. We alluded to the fact that we believed CIGX qualified as a rebound play. The stock did trade sideways for a few days, and now, over the past two days we have begun to witness some slow and steady gains.

On Thursday, CIGX cracked into the top -gainers list for NASDAQ stocks. It is always impressive when a NASDAQ stock can increase in value 7% in a single day.

Autumn was a huge season for this stock last year, when the PPS doubled in just a few short months. We are anxious to see what activity this fall season will bring to CIGX.

BioCurex, Inc BOCX

Yesterday, BOCX had some earth-shattering news, as the stock price compounded by more than 175%, and this, on forty-four times its 3-month average volume.

When momentum stocks like this hit our radar screen, we like to keep them high on our watchlist as heavy movers with a high bounce probability.

This morning, we foresee a possible gap up followed by a pullback, which we see as a good opportunity to get in for a quick flip on the bounce. Ultimately we will be watching BOCX closely for the dust to settle after yesterday’s excitement.

Here is the huge news that caused all this commotion:

BioCurex’s RECAF(TM) Blood Test for Cancer Can Prevent Two Thirds of Unnecessary Prostate Biopsies

RICHMOND, British Columbia, Sep 8, 2011 (GlobeNewswire via COMTEX) — BioCurex Inc. (OTCBB:BOCX) today announced results indicating that its RECAF blood test for cancer can prevent 70% of unnecessary prostate biopsies.

In a study to be presented at the ISOBM (International Society of Oncology and Biomarkers) annual meeting in October, BioCurex compared the performance of RECAF and free-PSA to discriminate prostate cancer from benign prostate hyperplasia (BPH), a common benign condition that requires no surgical treatment. The RECAF test outperformed the established free-PSA test by approximately 600% in its ability to prevent unnecessary prostate biopsies.

Get Our FREE Daily Reports!

SUBSCRIBE